# US 2012/0253071 A1 · Sterilization of biodegradable hydrogels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253071 A1
- Document ID: US20120253071A1
- Status: Published application
- Kind: A1
- Application number: 13/505,214
- Filed: 2010-10-28
- Published: 2012-10-04
- Earliest claimed: 2009-10-29
- Assignees: Ascendis Pharma A/S
- Inventors: Harald Rau; Tobias Voigt; Ulrich Hersel
- Web page: https://patentgrep.com/patent/US20120253071A1

## CPC

- A61K 47/6903: {the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel}
- A61K 41/17: by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
- A61L 2/081: Gamma radiation
- A61L 2/10: Ultraviolet [UV] radiation
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C08G 65/329: with organic compounds
- C08L 71/02: Polyalkylene oxides
- A61L 2103/05: Living organisms or biological materials
- C08L 2203/02: for biomedical use
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention relates to a terminal sterilization process for biodegradable PEG-based insoluble hydrogels using irradiation. The presence of a protective solvent ensures that the hydrogel remains intact with functionally preserved three-dimensional and physicochemical properties.

## Claims

### Claim 1

A method for sterilizing a biodegradable poly(ethylene glycol) based insoluble hydrogel comprising backbone moieties which are interconnected by hydrolytically degradable bonds, the method comprising the steps of:
(a) Providing the hydrogel;
(b) Solvating the hydrogel in a protective solvent or in a mixture of two or more protective solvents or aqueous solutions thereof; and
(c) Subjecting the solvated hydrogel to gamma radiation.

### Claim 2 (depends on 1)

The method of claim 1;
wherein the protective solvent is acetic acid (aqueous solution, 0.05-1% (v/v)), acetonitrile, 4-acetylmorpholine, dimethylsulfoxide, dichloromethane, N,N-dimethylacetamide, dimethylcarbonate, dimethylformamide, 1-ethyl-2-pyrrolidone, N-ethylacetamide, N-ethylformamide, 4-formylmorpholine, l-formylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, 1,3-dimethyl-2-imidazolidinone, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone, alkyl alcohols, formamide, hexamethylphosphoramide, IV-methylacetamide, nicotinamide (aqueous solution, 0.1-5% (w/w)), pyridoxine (aqueous solution, 0.1-5% (w/w), N-methylformamide, NMP, 1,2-propylene carbonate, tetrahydrofuran, sulfolan, water, or mixtures thereof.

### Claim 3 (depends on 1)

The method of claim 1;
wherein the protective solvent is NMP, DMA, DMF, or DMI.

### Claim 4 (depends on 1)

The method of claim 1;
wherein sterilization is obtained with gamma radiation with a dose of from 5 to 100 kGy.

### Claim 5 (depends on 1)

The method of claim 1;
wherein sterilization is obtained with gamma radiation with a dose of from 8 to 50 kGy.

### Claim 6 (depends on 1)

The method of claim 1;
wherein the hydrogel is loaded with small molecule biologically active moieties.

### Claim 7 (depends on 1)

The method of claim 1:
wherein the backbone moieties of the hydrogel have each a molecular weight in the range of from 1 kDa to 20 kDa.

### Claim 8 (depends on 1)

The method of claim 1;
wherein the backbone moieties of the hydrogel are interconnected by hydrolytically degradable bonds; and
wherein the backbone moieties are linked together through crosslinker moieties, each crosslinker moiety being terminated by at least two of the hydrolytically degradable bonds.

### Claim 9 (depends on 1)

The method of claim 1;
wherein the hydrolytically degradable bonds are carboxylic esters, carbonates, phosphoesters, or sulfonic acid esters.

### Claim 10 (depends on 8)

The method of claim 8;
wherein the crosslinker moieties have a molecular weight in the range of from 60 Da to 5 kDa.

### Claim 11 (depends on 1)

The method of claim 1;
wherein the backbone moieties of the biodegradable PEG based insoluble hydrogel comprise a branching core of the following formula:
wherein the dashed line indicates attachment to the remainder of the backbone moiety.

### Claim 12 (depends on 1)

The method of claim 1;
wherein the backbone moieties of the biodegradable PEG based insoluble hydrogel comprise a structure of the following formula:
wherein n is an integer of from 5 to 50, and the dashed line indicates attachment to the rest of the molecule.

### Claim 13 (depends on 1)

The method of claim 1;
wherein the backbone moieties of the biodegradable PEG based insoluble hydrogel comprise a hyperbranched moiety Hyp.

### Claim 14 (depends on 13)

The method of claim 13;
wherein the backbone moieties of the biodegradable PEG based insoluble hydrogel comprise a hyperbranched moiety Hyp of the following formula:
wherein the dashed lines indicate attachment to the rest of the molecule and carbon atoms marked with asterisks indicate S-configuration.

### Claim 15 (depends on 13)

The method of claim 13;
wherein the backbone moieties are attached to at least one spacer of the following formula:
wherein one of the dashed lines indicates attachment to the hyperbranched moiety Hyp, and the second dashed line indicates attachment to the rest of the molecule; and
wherein m is an integer of from 2 to 4.

### Claim 16 (depends on 1)

The prodrug of claim 1;
wherein the backbone moieties are linked together through crosslinker moieties comprising the following structure:
wherein q is an integer from 3 to 100.

### Claim 17 (depends on 1)

The method of claim 1;
wherein the protective solvent contains one or more protecting agents.

### Claim 18 (depends on 17)

The method of claim 17;
wherein the protecting agents are selected from propylamine, butylamine, pentylamine, sec. butylamine, ethanolamine, diethanolamine, serinol, trishydroxymethyl-aminomethane, acetic acid, formic acid, ascorbic acid, glycineamide, pivalic acid, propanoic acid, succinic acid, glutaric acid, adipic acid, thioglycerin, dithiothreitol, mercaptoethanol, and reduced glutathione.

### Claim 19 (depends on 1)

A sterilized biodegradable PEG-based insoluble hydrogel obtainable by any of the method of claim 1.
